What systemic therapy would you consider, if any, for an isolated but multifocal CNS recurrence of HER2+ HR negative breast cancer treated with local therapy (>4 lesions treated with resection and SRS)?
Patient completed neoadjuvant therapy with TCH 2 years prior, and has no evidence of disease outside the CNS on PET/CT.
Community PollStarted
What systemic therapy would you use in addition to local therapy for a HER2+HR- isolated CNS recurrence?
131 physicians have voted
Join Mednetto vote and see how they answered.
1 Answer
Mednet MemberInvited Expert
Medical Oncology · H Lee Moffitt Cancer Center, University of South Florida
Answered on
There is not an agreed-upon standard approach, nor am I aware of definitive data supporting one approach over another. My preferred approach to managing isolated CNS relapses that are treated locally with no visible systemic disease is to do trastuzumab plus a TKI with no chemo (like EGF104900 regim...
Join for free or sign in to see the full answer